Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Genevieve Douglas, Claire Harrison, Cecily Forsyth, Michael Bennett, William Stevenson, John Hounsell, Sumita Ratnasingam, David Ritchie, David M. Ross & Andrew Grigg. (2017) Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Leukemia & Lymphoma 58:1, pages 89-95.
Read now
Read now
Animesh Pardanani & Ayalew Tefferi. (2014) Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?. Leukemia & Lymphoma 55:12, pages 2706-2711.
Read now
Read now
Articles from other publishers (7)
Jan Philipp Bewersdorf, Joan How, Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, John Mascarenhas & Raajit K. Rampal. (2023) Moving toward disease modification in polycythemia vera. Blood 142:22, pages 1859-1870.
Crossref
Crossref
Can Baykal, Kübra Nursel Bölük, Sıla Kılıç Sayar, Şule Öztürk Sarı, Amid Mahmudov & Nesimi Büyükbabani. (2022) Precancerous skin lesions and malignant skin tumors associated with hydroxyurea treatment: Evaluation of a large series and review of the literature. TURKDERM 56:4, pages 159-165.
Crossref
Crossref
Divya R Gavini, Dhairya J Salvi, Prutha H Shah, Davuluri Uma, Jun Hee Lee & Pousette Hamid. (2021) Non-melanoma Skin Cancers in Patients on Hydroxyurea for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Systematic Review. Cureus.
Crossref
Crossref
Giulia Spallone, Pietro Sollena, Alessandra Ventura, Maria C. Fargnoli, Carlota Gutierrez, Alfredo Piccerillo, Sara Tambone, Luca Bianchi & Ketty Peris. (2019) Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities. Dermatologic Therapy 32:6.
Crossref
Crossref
Marián Švajdler, Roman Mezencev, Jana Kašpírková, Denisa Kacerovská, Dmitry V. Kazakov, Ondrej Ondič & Michal Michal. (2016) Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients. The American Journal of Dermatopathology 38:10, pages 751-757.
Crossref
Crossref
Montse G?mez, Vicent Guillem, Arturo Pereira, Francisca Ferrer-Mar?n, Alberto ?lvarez-Larr?n, Ana Kerguelen, Nat?lia Estrada, Joaqu?n Mart?nez-L?pez, Anna Angona, Paula Amat, Blanca Navarro, Carles Besses & Juan-Carlos Hern?ndez-Boluda. (2016) Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera. European Journal of Haematology 96:3, pages 285-290.
Crossref
Crossref
Mads Emil Bjørn & Hans Carl Hasselbalch. (2015) The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms. Mediators of Inflammation 2015, pages 1-11.
Crossref
Crossref